A leader sequence capable of enhancing RNA expression and protein synthesis in mammalian cells

Protein Science

Volumn 22, Issue 10, 2013, Pages 1392-1398

  Wellensiek, Brian P ^a   Larsen, Andrew C ^a   Flores, Julia ^a   Jacobs, Bertram L ^a,b   Chaput, John C ^a  

^a ARIZONA STATE UNIVERSITY   (United States)

^b ARIZONA STATE UNIVERSITY   (United States)

Author keywords

Human vaccinia virus; Mammalian cell culture; Recombinant protein synthesis; Translation enhancing elements

Indexed keywords

PLASMID DNA; PROTEIN; RNA; SIGNAL PEPTIDE;

ANIMAL CELL; ARTICLE; BIOTECHNOLOGY; CELL STRAIN HEK293; CONTROLLED STUDY; EMBRYO; EXPRESSION VECTOR; FEMALE; GENE EXPRESSION SYSTEM; HELA CELL; HUMAN; HUMAN CELL; IN VITRO SELECTION; MAMMAL CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RNA SEQUENCE; TRANSGENE; VACCINIA VIRUS;

HUMAN VACCINIA VIRUS; MAMMALIAN CELL CULTURE; RECOMBINANT PROTEIN SYNTHESIS; TRANSLATION ENHANCING ELEMENTS;

5' UNTRANSLATED REGIONS; ANIMALS; BIOTECHNOLOGY; CELL LINE; CRICETINAE; GENE EXPRESSION; GENETIC VECTORS; HEK293 CELLS; HELA CELLS; HUMANS; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS, GENETIC; RECOMBINANT PROTEINS; RNA, MESSENGER; VACCINIA VIRUS;

EID: 84892926824     PISSN: 09618368     EISSN: 1469896X     Source Type: Journal    
DOI: 10.1002/pro.2325     Document Type: Article

References (16)

1. Zhu J (2012) Mammalian cell protein expression for biopharmaceutical production.Biotechnol Adv 30:1158-1170.
2. Wurm FM (2004) Production of recombinant protein therapeutics in cultivated mammalian cells. Nat Biotechnol 22:1393-1398.
3. Schmidt FR (2004) Recombinant expression systems in the pharmaceutical industry. Appl Microbiol Biotechnol 65:363-372.
4. Swiech K, Picanco-Castro V, Covas DT (2012) Human cells: New platform for recombinant therapeutic protein production. Protein Expr Purif 84:147-153.
5. Colosimo A, Goncz KK, Holmes AR, Kunzelmann K, Novelli G, Malone RW, Bennett MJ, Gruenert DC (2000) Transfer and expression of foreign genes in mammalian cells. BioTechniques 29:314-331.
6. Yin J, Li G, Ren X, Herrler G (2007) Select what you need: A comparative evaluation of the advantages and limitations of frequently used expression systems for foreign genes. J Biotechnol 127:335-347.
7. Demain AL, Vaishnav P (2009) Production of recombinant proteins by microbes and higher organisms. Biotechnol Adv 27:297-306.
8. Jacobs BL, Langland JO, Kibler KV, Denzler KL, White SD, Holechek SA, Wong S, Huynh T, Baskin CR (2009) Vaccinia virus vaccines: Past, present and future. Antiviral Res 84:1-13.
9. Wellensiek BP, Larsen, AC, Stephens B, Kukurba K, Waern K, Briones N, Liu L, Snyder M, Jacobs BL, Kumar S, Chaput JC (2013) Genome-Wide profiling of human cap-Independent translation enhancing elements. Nat Methods 10:747-750.
10. Elfakess R, Dikstein R (2008) A translation initiation element specific to mRNAs with very short 50UTR that also regulates transcription. PLoS One 3:e3094.
11. Schwer B, Visca P, Vos JC, Stunnenberg HG (1987) Discontinuous transcription or RNA processing of vaccinia virus late messengers results in a 50 poly(A) leader. Cell 50:163-169.
12. Fuerst TR, Niles EG, Studier FW, Moss B (1986) Eukaryotic transient-Expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase. Proc Natl Acad Sci USA 83:8122-8126.
13. Hebben M, Brants J, Birck C, Samama JP, Wasylyk B, Spehner D, Pradeau K, Domi A, Moss B, Schultz P, Drillien R (2007) High level protein expression in mammalian cells using a safe viral vector: Modified vaccinia virus Ankara. Protein Expr Purif 56:269-278.
14. Elroy-Stein O, Fuerst TR, Moss B (1989) Cap-Independent translation of mRNA conferred by encephalomyocarditis virus 50 sequence improves the performance of the vaccinia virus/bacteriophage T7 hybrid expression system. Proc Natl Acad Sci USA 86:6126-6130.
15. Drexler I, Heller K, Wahren B, Erfle V, Sutter G (1998) Highly attenuated modified vaccinia virus Ankara replicates in baby hamster kidney cells, a potential host for virus propagation, but not in various human transformed and primary cells. J Gen Virol 79:347-352.
16. Bussow K, Scheich C, Sievert V, Harttig U, Schultz J, Simon B, Bork P, Lehrach H, Heinemann U (2005) Structural genomics of human proteins-Target selection and generation of a public catalogue of expression clones. Microbial Cell Factories 4:21.